High quality process of care increases one-year survival after acute myocardial infarction (AM I): A cohort study in Italy

被引:8
|
作者
Ventura, Martina [1 ]
Belleudi, Valeria [1 ]
Sciattella, Paolo [2 ]
Di Domenicantonio, Riccardo [1 ]
Di Martino, Mirko [1 ]
Agabiti, Nera [1 ]
Davoli, Marina [1 ]
Fusco, Danilo [1 ]
机构
[1] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
[2] Sapienza Univ Rome, Dept Stat Sci, Rome, Italy
来源
PLOS ONE | 2019年 / 14卷 / 02期
关键词
ST-SEGMENT ELEVATION; TO-BALLOON TIME; ACUTE CORONARY SYNDROMES; OBSTRUCTIVE PULMONARY-DISEASE; LONG-TERM MORTALITY; PRIMARY ANGIOPLASTY; MEDICAL THERAPY; SECONDARY PREVENTION; HOSPITAL MORTALITY; IMPACT;
D O I
10.1371/journal.pone.0212398
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The relationship between guideline adherence and outcomes in patients with acute myocardial infarction (AMI) has been widely investigated considering the emergency, acute, post acute phases separately, but the effectiveness of the whole care process is not known. Aim The study aim was to evaluate the effect of the multicomponent continuum of care on 1-year survival after AMI. Methods We conducted a cohort study selecting all incident cases of AMI from health information systems during 2011-2014 in the Lazio region. Patients' clinical history was defined by retrieving previous hospitalizations and drugs prescriptions. For each subject the probability to reach the hospital and the conditional probabilities to survive to 30 days from admission and to 31-365 days post discharge were estimated through multivariate logistic models. The 1-year survival probability was calculated as the product of the three probabilities. Quality of care indicators were identified in terms of emergency timeliness (time between residence and the nearest hospital), hospital performance in treatment of acute phase (number/timeliness of PCI on STEMI) and drug therapy in post-acute phase (number of drugs among anti platelet, (beta-blockers, ACE inhibitors/ARBs, statins). The 1-year survival Probability Ratio (PR) and its Bootstrap Confidence Intervals (BCI) between who were exposed to the highest level of quality of care (timeliness<10', hospitalization in high performance hospital, complete drug therapy) and who exposed to the worst (timeliness >= 10', hospitalization in low performance hospital, suboptimal drug therapy) were calculated fora mean-severity patient and varying gender and age. PRs for patients with diabetes and COPD were also evaluated. Results We identified 38,517 incident cases of AMI. The out-of-hospital mortality was 27.6%. Among the people arrived in hospital, 42.9% had a hospitalization for STEMI with 11.1% of mortality in acute phase and 5.4% in post-acute phase. For a mean-severity patient the PR was 1.19 (BCI 1.14-1.24). The ratio did not change by gender, while it moved from 1.06 (BCI 1.05-1.08) for age<65 years to 1.62 (BCI 1.45-1.80) for age >85 years. For patients with diabetes and COPD a slight increase in PRs was also observed. Conclusions The 1-year survival probability post AMI depends strongly on the quality of the whole multi component continuum of care. Improving the performance in the different phases, taking into account the relationship among these, can lead to considerable saving of lives, in particular for the elderly and for subjects with chronic diseases.
引用
收藏
页数:15
相关论文
共 21 条
  • [1] Predictors of One-year Mortality in Older Patients With Myocardial Infarction: Results of a Cohort Study
    Saleh, Nahid
    Abasi, Farid
    Bavandpouri, Sousan Mahmoudi
    Motevaseli, Sayeh
    SALMAND-IRANIAN JOURNAL OF AGEING, 2024, 19 (03): : 470 - 483
  • [2] One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database
    Martin-Latry, Karin
    Latry, Philippe
    Berges, Camille
    Coste, Pierre
    Douard, Herve
    Pucheu, Yann
    Couffinhal, Thierry
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2022, 115 (02) : 78 - 86
  • [3] High thrombotic risk increases adverse clinical events up to 5 years after acute myocardial infarction. A nationwide retrospective cohort study
    Mureddu, Gian Francesco
    Greco, Cesare
    Rosato, Stefano
    D'Errigo, Paola
    De Luca, Leonardo
    Badoni, Gabriella
    Faggiano, Pompilio
    Seccareccia, Fulvia
    MONALDI ARCHIVES FOR CHEST DISEASE, 2019, 89 (03) : 29 - 36
  • [4] Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011
    Gitsels, Lisanne A.
    Kulinskaya, Elena
    Steel, Nicholas
    BMJ OPEN, 2017, 7 (01):
  • [5] Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI
    Droz-Perroteau, Cecile
    Blin, Patrick
    Dureau-Pournin, Caroline
    Thomas, Daniel
    Danchin, Nicolas
    Tricoire, Jacques
    Paillard, Francois
    Hercberg, Serge
    Guize, Louis
    Guiard, Estelle
    Maizi, Helene
    Bernard, Marie-Agnes
    Benichou, Jacques
    Moore, Nicholas
    THERAPIE, 2019, 74 (04): : 459 - 468
  • [6] Discharge Pharmacotherapies and One-Year Heart Failure Rehospitalization in Nationwide Study of 35,192 Patients With Acute Myocardial Infarction
    Chen, Ruth W.
    Zheng, Huili
    Hausenloy, Derek
    Sahlen, Anders
    Tan, Jack W.
    Chua, Terrance S.
    Tan, Huay-Cheem
    Yeo, Tiong-Cheng
    Ho, Hee-Hwa
    Tong, Khim-Leng
    Foo, Ling-Li
    Richards, A. Mark
    Chan, Mark Y.
    CIRCULATION, 2018, 138
  • [7] Clinical impacts of high-sensitivity C-reactive protein reduction for secondary prevention in Asian patients with one-year survivor after acute myocardial infarction
    Kim, Hyun Kuk
    Jeong, Myung Ho
    Seo, Hyeong Won
    Ahn, Joon Ho
    Cho, Kyung Hoon
    Hong, Young Joon
    Kim, Ju Han
    Ahn, Youngkeun
    Cho, Jeong Gwan
    Park, Jong Chun
    Park, Kyung Woo
    Kim, Hyo-Soo
    Lee, Sang Rok
    Chae, Jei Keon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 193 : 20 - 22
  • [8] Smoking Status and Long-Term Survival After First Acute Myocardial Infarction A Population-Based Cohort Study
    Gerber, Yariv
    Rosen, Laura J.
    Goldbourt, Uri
    Benyamini, Yael
    Drory, Yaacov
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (25) : 2382 - 2387
  • [9] Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy
    Kirchmayer, U.
    Agabiti, N.
    Belleudi, V.
    Davoli, M.
    Fusco, D.
    Stafoggia, M.
    Arca, M.
    Barone, A. P.
    Perucci, C. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (01) : 37 - 44
  • [10] Quality of acute myocardial infarction care in England and Wales during the COVID-19 pandemic: linked nationwide cohort study
    Aktaa, Suleman
    Yadegarfar, Mohammad E.
    Wu, Jianhua
    Rashid, Muhammad
    de Belder, Mark
    Deanfield, John
    Schiele, Francois
    Minchin, Mark
    Mamas, Mamas
    Gale, Chris P.
    BMJ QUALITY & SAFETY, 2022, 31 (02) : 116 - 122